These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18812428)

  • 1. Paraneoplastic scleroderma secondary to hairy cell leukaemia successfully treated with cladribine.
    Juarez M; Marshall R; Denton C; Evely R
    Rheumatology (Oxford); 2008 Nov; 47(11):1734-5. PubMed ID: 18812428
    [No Abstract]   [Full Text] [Related]  

  • 2. Panuveitis responsive to 2-CdA: an unusual ocular presentation of hairy cell leukemia.
    Zeidman A; Floru S; Robinson A; Polliack A; Djaldeti M; Savir H; Mittelman M
    Leuk Lymphoma; 1996 Feb; 20(5-6):501-3. PubMed ID: 8833410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rash in a hairy situation: Leukocytoclastic vasculitis at presentation of hairy cell Leukemia.
    Moyers JT; Liu LW; Ossowski S; Goddard L; Kamal MO; Cao H
    Am J Hematol; 2019 Dec; 94(12):1433-1434. PubMed ID: 31364185
    [No Abstract]   [Full Text] [Related]  

  • 4. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine].
    Miyazaki M; Taguchi A; Sakuragi S; Mitani N; Matsuda K; Shinohara K
    Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hairy cell leukemia with cladribine].
    Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
    Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hairy cell leukemia: Part II: therapy with cladribine].
    Barth J; Rummel MJ
    Med Monatsschr Pharm; 2009 Jul; 32(7):252-60. PubMed ID: 19731753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A paraneoplastic membranoproliferative glomerulonephritis with isolated C3 deposits associated with hairy cell leukaemia.
    Abboud I; Galicier L; De Labarthe A; Dossier A; Glotz D; Verine J
    Nephrol Dial Transplant; 2010 Jun; 25(6):2026-8. PubMed ID: 20335271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairy cell leukemia with concurrent cryptococcus infection.
    Audeh YM; Gruszecki AC; Cherrington A; Reddy VV
    Am J Hematol; 2003 Mar; 72(3):223-4. PubMed ID: 12605398
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebral tuberculomas in a patient with hairy cell leukaemia treated with cladribine.
    Fonseca SB; de Oliveira JR; Gonçalves C; Lopes V
    BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 27927706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of one hairy cell leukemia case with single course of cladribine].
    Zhang LJ; Qiu HX; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):336. PubMed ID: 21729604
    [No Abstract]   [Full Text] [Related]  

  • 12. Cryptococcal meningitis occurring at 19 months after cladribine therapy for hairy cell leukemia.
    Ikpeazu EV; Kaplon MK
    Eur J Haematol; 1998 Oct; 61(4):286-7. PubMed ID: 9820640
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effectiveness of cladribine and cellular immunodeficiency--related effects in hairy-cell leukemia?].
    Raida L; Papajík T; Pikalová Z; Zapletalová J; Indrák K
    Vnitr Lek; 2002 May; 48(5):384-9. PubMed ID: 12061204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
    Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M
    Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472
    [No Abstract]   [Full Text] [Related]  

  • 15. [2-chlorodeoxyadenosine (2-CdA) cladribine therapy in hairy cell leukemia].
    Raanani P; Shpilberg O; Ben-Bassat I
    Harefuah; 1994 Jun; 126(11):673-6. PubMed ID: 7927005
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
    Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairy cell leukemia and sarcoidosis: a case report and review of the literature.
    Schiller G; Said J; Pal S
    Leukemia; 2003 Oct; 17(10):2057-9. PubMed ID: 14513061
    [No Abstract]   [Full Text] [Related]  

  • 18. Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosis.
    Hilbe W; Berger T; Konwalinka G; Thaler J
    Acta Haematol; 1999; 102(2):99-100. PubMed ID: 10529514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
    Greyz N; Saven A
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine.
    Tombak A; Aygün S; Serinsöz E; Tiftik EN
    Korean J Intern Med; 2015 Sep; 30(5):739-41. PubMed ID: 26354071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.